CDKN2A Antibody

Product Specifications

NCBI Gene ID

1029

Swiss Prot

P42771

Accession Number

NP_000068.1, NP_001182061.1

Host

Goat

Reactivity

Human

Immunogen

The immunogen for this antibody is: C-HARIDAAEGPSDIPD

Clonality

Polyclonal

Conjugation

Unconjugated

Type

Primary Antibodies

Field of Research

Homeostasis, Signal Transduction, Cancer

Purification

Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.

Positive Control

Cat. No. 1201 - HeLa Cell Lysate

Concentration

500 ug/mL

Buffer

Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin. Aliquot and store at -20°C. Minimize freezing and thawing.

Modification

None

Shipping Conditions

Blue Ice

Storage Conditions

Aliquot and store at -20˚ C. Minimize freezing and thawing.

Specificity

This antibody is expected to recognise isoform p16INK4a (NP_000068.1) and isoform p16gamma (NP_001182061.1) .

Applications Notes

Peptide ELISA: Western Blot:Immunohistochemistry:

Symbol

CDKN2A

NCBI Official Name

Cyclin-dependent kinase inhibitor 2A

NCBI Organism

Homo sapiens

Background Reference 01

Mawrin C, Kirches E, Schneider-Stock R, Boltze C, Vorwerk CK, von Mawrin A, Kirches E, Schneider-Stock R, Boltze C, Vorwerk CK, von Mawrin A, Kirches E, Schneider-Stock R, Boltze C, Vorwerk CK, von Mawrin A, Kirches E, Schneider-Stock R, Boltze C, Vorwerk Alterations of cell cycle regulators in gliomatosis cerebri. J Neurooncol. 2005 Apr;72 (2) :115-22.

Other Product Names

CDKN2A, p16INK4a, cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4), HGNC:1787, ARF, CDK4I, CDKN2, CMM2, INK4, INK4a, MLM, MTS1, TP16, p14, p14ARF, p16, p16INK4, p19 , CDK4 inhibitor p16-INK4, cell cycle negative regulator beta, cyclin-